Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jul;21(7):722-7.
doi: 10.1111/j.1525-1497.2006.00458.x.

The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism

Frederick A Spencer  1 , Cathy Emery, Darleen Lessard, Frederick Anderson, Sri Emani, Jayashri Aragam, Richard C Becker, Robert J Goldberg
Affiliations

The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism

Frederick A Spencer et al. J Gen Intern Med. 2006 Jul.

Abstract

Background: While there have been marked advances in diagnostic and therapeutic strategies for venous thromboembolism, our understanding of its clinical epidemiology is based on studies conducted more than a decade ago.

Objective: The purpose of this observational study was to describe the incidence and attack rates of venous thromboembolism in residents of the Worcester Statistical Metropolitan Area in 1999. We also describe demographic and clinical characteristics, management strategies, and associated hospital and 30-day outcomes.

Design and measurements: The medical records of all residents from Worcester, MA (2000 census=477,800), diagnosed with International Classification of Diseases, 9th revision (ICD-9) codes consistent with possible venous thromboembolism during 1999 were independently validated, classified, and reviewed by trained abstractors.

Results: A total of 587 subjects were enrolled with validated venous thromboembolism. The incidence and attack rates of venous thromboembolism were 104 and 128 per 100,000 population, respectively. Three quarters of patients developed their venous thromboembolism in the outpatient setting - a substantial proportion of these patients had undergone recent surgery or had a recent prior hospitalization. Less than half of the patients received anticoagulant prophylaxis during high-risk periods before their venous thromboembolism. Thirty-day rates of venous thromboembolism recurrence, major bleeding, and mortality were 4.8%, 7.7%, and 6.6%, respectively.

Conclusion: These data provide insights into recent incidence and attack rates, changing patient profiles, management strategies, and subsequent outcomes in patients with venous thromboembolism. The underutilization of prophylaxis before venous thromboembolism, and relatively high 30-day recurrence rates, suggest a continued need for the improvement of venous thromboembolism prophylaxis and management in the community.

PubMed Disclaimer

References

    1. Morbidity and Mortality: 1998 Chartbook on Cardiovascular, Lung and Blood Diseases. National Institutes of Health. National Heart, Lung, and Blood Institute. 1998. October.
    1. Anderson FA, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 1991;151:933–8. - PubMed
    1. Anderson FA, Jr., Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A, Patwardin NA. Physician practices in the prevention of venous thromboembolism. Ann Intern Med. 1991;115:591–5. - PubMed
    1. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton JL. Trends in the incidence of deep vein thrombosis and pulmonary embolism. A 25-year population-based study. Arch Intern Med. 1998;158:585–93. - PubMed
    1. Heit JA. Venous thromboembolism: disease burdens, outcomes, and risk factors. J Haemost Thromb. 2005;3:1611–7. - PubMed

Publication types